| Application no. and date | 17783207.8 (espacenet) (Federated) (European Patent Register), 20170414 | | Patent/reg. no. and date | DK/EP 3442600, 20240313 | | Publication date | 20190220 | | Priority no. and date | US 201662323333 P, 20160415, US 201662433548 P, 20161213 | | EP pub. no. and date |
EP 3442600 20190220 | | Effective date | | | Applicant/owner | Research Institute at Nationwide
Children's Hospital, 700 Children's Drive, Room W172,
Columbus, Ohio 43205, US | | Applicant ref. no. | 1699687 | | Inventor | MENDELL, Jerry, R., 8176 Copperfield Drive
Columbus, OH 43235, US,
RODINO-KLAPAC, Louise, 4912 Bixby Ridge Drive E
Groveport,OH 43125, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , A61P 21/00 (2006.01) , C07K 14/47 (2006.01) , C12N 15/12 (2006.01) , C12N 15/85 (2006.01) | | Title | ADENOASSOCIERET VIRUSVEKTORFREMFØRING AF ß-SARCOGLYCAN OG MIKRORNA-29 OG BEHANDLING AF MUSKELDYSTROFI | | Int. application no. | US2017027583 | | Int. publication no. | WO2017180976 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
